Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinomaJoseph J. Caumanns, Steven de Jong|Cancer Letters|2019Cited by 58
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell CarcinomaJoseph J. Caumanns, Steven de Jong|Clinical Cancer Research|2018Cited by 52